ID   ST17B_RAT               Reviewed;         371 AA.
AC   Q91XS8;
DT   28-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   29-MAY-2024, entry version 142.
DE   RecName: Full=Serine/threonine-protein kinase 17B;
DE            EC=2.7.11.1;
DE   AltName: Full=DAP kinase-related apoptosis-inducing protein kinase 2;
GN   Name=Stk17b; Synonyms=Drak2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116 {ECO:0000312|EMBL:BAB63368.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH CHP1, TISSUE
RP   SPECIFICITY, SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-62.
RC   TISSUE=Brain {ECO:0000312|EMBL:BAB63368.1};
RX   PubMed=11481038; DOI=10.1093/oxfordjournals.jbchem.a002975;
RA   Matsumoto M., Miyake Y., Nagita M., Inoue H., Shitakubo D., Takemoto K.,
RA   Ohtsuka C., Murakami H., Nakamura N., Kanazawa H.;
RT   "A serine/threonine kinase which causes apoptosis-like cell death interacts
RT   with a calcineurin B-like protein capable of binding Na+/H+ exchanger.";
RL   J. Biochem. 130:217-225(2001).
RN   [2]
RP   FUNCTION AS A MYOSIN LIGHT CHAIN KINASE, AUTOPHOSPHORYLATION, AND
RP   MUTAGENESIS OF LYS-62.
RX   PubMed=12966074; DOI=10.1093/jb/mvg137;
RA   Kuwahara H., Kamei J., Nakamura N., Matsumoto M., Inoue H., Kanazawa H.;
RT   "The apoptosis-inducing protein kinase DRAK2 is inhibited in a calcium-
RT   dependent manner by the calcium-binding protein CHP.";
RL   J. Biochem. 134:245-250(2003).
CC   -!- FUNCTION: Acts as a positive regulator of apoptosis. Phosphorylates
CC       myosin light chains. {ECO:0000269|PubMed:11481038,
CC       ECO:0000269|PubMed:12966074}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:11481038};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:11481038};
CC   -!- SUBUNIT: Interacts with CHP1; the interaction induces CHP1 to
CC       translocate from the Golgi to the nucleus.
CC       {ECO:0000269|PubMed:11481038}.
CC   -!- INTERACTION:
CC       Q91XS8; P61023: Chp1; NbExp=6; IntAct=EBI-77460, EBI-917838;
CC       Q91XS8; Q9Z1Y0: Rhov; NbExp=2; IntAct=EBI-77460, EBI-77480;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11481038}. Cell
CC       membrane {ECO:0000269|PubMed:11481038}. Endoplasmic reticulum-Golgi
CC       intermediate compartment {ECO:0000269|PubMed:11481038}.
CC       Note=Colocalizes with STK17B at the plasma membrane.
CC   -!- TISSUE SPECIFICITY: Highly expressed in thymus, spleen, and testis,
CC       lower levels present in the brain. {ECO:0000269|PubMed:11481038}.
CC   -!- PTM: Autophosphorylated.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. DAP kinase subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB070349; BAB63368.1; -; mRNA.
DR   PIR; JC7733; JC7733.
DR   RefSeq; NP_596883.1; NM_133392.1.
DR   RefSeq; XP_006244970.1; XM_006244908.2.
DR   AlphaFoldDB; Q91XS8; -.
DR   SMR; Q91XS8; -.
DR   IntAct; Q91XS8; 2.
DR   STRING; 10116.ENSRNOP00000016857; -.
DR   iPTMnet; Q91XS8; -.
DR   PhosphoSitePlus; Q91XS8; -.
DR   PaxDb; 10116-ENSRNOP00000016857; -.
DR   Ensembl; ENSRNOT00000016856.5; ENSRNOP00000016857.1; ENSRNOG00000012502.5.
DR   Ensembl; ENSRNOT00055007559; ENSRNOP00055005680; ENSRNOG00055004754.
DR   Ensembl; ENSRNOT00060039686; ENSRNOP00060032826; ENSRNOG00060022912.
DR   Ensembl; ENSRNOT00065004420; ENSRNOP00065003146; ENSRNOG00065003146.
DR   GeneID; 170904; -.
DR   KEGG; rno:170904; -.
DR   UCSC; RGD:620457; rat.
DR   AGR; RGD:620457; -.
DR   CTD; 9262; -.
DR   RGD; 620457; Stk17b.
DR   eggNOG; KOG0032; Eukaryota.
DR   GeneTree; ENSGT00940000154014; -.
DR   HOGENOM; CLU_000288_63_0_1; -.
DR   InParanoid; Q91XS8; -.
DR   OMA; LSHPWLW; -.
DR   OrthoDB; 5474191at2759; -.
DR   PhylomeDB; Q91XS8; -.
DR   TreeFam; TF314166; -.
DR   PRO; PR:Q91XS8; -.
DR   Proteomes; UP000002494; Chromosome 9.
DR   Bgee; ENSRNOG00000012502; Expressed in thymus and 20 other cell types or tissues.
DR   GO; GO:0015629; C:actin cytoskeleton; IMP:UniProtKB.
DR   GO; GO:0005793; C:endoplasmic reticulum-Golgi intermediate compartment; IEA:UniProtKB-SubCell.
DR   GO; GO:0090543; C:Flemming body; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IMP:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:2000271; P:positive regulation of fibroblast apoptotic process; ISS:UniProtKB.
DR   GO; GO:0012501; P:programmed cell death; IDA:RGD.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   CDD; cd14198; STKc_DRAK2; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR042763; ST17B_STKc.
DR   PANTHER; PTHR24342; SERINE/THREONINE-PROTEIN KINASE 17; 1.
DR   PANTHER; PTHR24342:SF5; SERINE_THREONINE-PROTEIN KINASE 17B; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; ATP-binding; Cell membrane; Kinase; Membrane;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..371
FT                   /note="Serine/threonine-protein kinase 17B"
FT                   /id="PRO_0000086708"
FT   DOMAIN          33..293
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          308..345
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        308..328
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        329..345
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        158
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         39..47
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         62
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MUTAGEN         62
FT                   /note="K->A: Inhibits kinase activity."
FT                   /evidence="ECO:0000269|PubMed:11481038,
FT                   ECO:0000269|PubMed:12966074"
SQ   SEQUENCE   371 AA;  42133 MW;  7BD4E83D98896F4F CRC64;
     MSRRRFDCRS ISGLLTTTPQ TPMKTENFNN FYTLTPKELG RGKFAVVRQC ISKSTGQEYA
     AKFLKKRRRG QDCRAEILHE IAVLELARSC PHVINLHEVY ETATEIILVL EYAAGGEIFN
     LCLPELAEMV SENDVIRLIK QILEGVHYLH QNNIVHLDLK PQNILLSSIY PLGDIKIVDF
     GMSRKIGNAS ELREIMGTPE YLAPEILNYD PITTATDMWN IGIIAYMLLT HTSPFVGEDN
     QETYLNISQV NVDYSEEMFS SVSQLATDFI QSLLVKNPEK RPTAESCLSH SWLQQWDFGS
     LFHPEETSES SQTQDLSLRS SEDKTPKSCN GSCGDREDKE NIPEDDSLLS KRFRFDDSLP
     SPHELVPDLF C
//
